학술논문
Phase II trial of eribulin in patients who do not achieve pathologic complete response (pCR) following neoadjuvant chemotherapy
Document Type
Article
Author
Source
In: Breast Cancer Research and Treatment . (Breast Cancer Research and Treatment, 1 April 2020, 180(3):647-655)
Subject
Language
English
ISSN
15737217
01676806
01676806